The long-acting GLP-1 drug had good overall tolerability with some GI bumps in weekly-to-monthly transition, while the A1c benefits raise hopes of a potential ‘game changer’ for T2D.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/weekly-and-monthly-berobenatide-show-weight-a1c-benefits-2026a1000jar?src=rss
Author :
Publish date : 2026-06-09 17:31:00
Copyright for syndicated content belongs to the linked Source.
